Impact Factor
2.59
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.02
83 total citations
h5-index
13
h5 depth signal
Cited share
48.8%
21 of 43
Total citations
83
Citation footprint
Metric signal
1.48
External metric anchor
Self-citation
3.6%
3 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
135
China
32
Ecuador
30
Japan
28
Sweden
28
Citing Fields of Research
Endocrinology & Metabolism
343
Diabetes
32
Cytogenetics
19
Musculoskeletal Disorders
14
Congenital Disorders
14
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,067
Articles tracked across the journal lifetime
Indexed publication set
43
21 cited publications
Last 12 months
40
3.6 publications/month
Open access share
17.5%
7 OA publications in the last year
Leading citing country
United States
135 citing publications
Leading citing field
Endocrinology & Metabolism
343 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v9n1,Feb. 1999-
v9n1,Feb. 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Endocrinology & Metabolism
Issuing & Sponsoring Bodies
Contributor
Growth Hormone Research Society
Contributor
International IGF Research Society
Broad Categories
Endocrinology
Endocrinology & Metabolism
MeSH Descriptors
Growth Hormone
Growth Substances
Somatomedins
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.ghir.2026.101729
Open DOI
Growth hormone deficiency after traumatic brain injury: Current insights and the need for preclinical modeling
02
03
DOI 10.1016/j.ghir.2026.101727
Open DOI
Benchmarking of growth hormone therapy in Hong Kong: ten-year data from the multi-centre GROWTH study
04
DOI 10.1016/j.ghir.2026.101728
Open DOI
Endocrine therapies and hormonal dysfunction after traumatic brain injury: A scoping review
05
06
07
DOI 10.1016/j.ghir.2026.101722
Open DOI
Fetal growth as an integrated maternal–placental–fetal system: What evidence can explain
08
DOI 10.1016/j.ghir.2026.101724
Open DOI
Estradiol cyclicity might contribute to the alterations in plasma GH1 protein levels across the menstrual cycle
09
DOI 10.1016/j.ghir.2026.101723
Open DOI
The GH-IGF axis in growth: An overview
10
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Merger of: Endocrinology and metabolism (London, England); and: Growth regulation, continuing the numbering of the latter.
Vol. 1, no. 1 (1999)19990408 Notice not published Printed on acid-free paper